Zucara Therapeutics Inc.
$550,000.00 CAD
≈ 7 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- June 1, 2020 – March 31, 2022
- Reference
- nrc-cnrc:172-2020-2021-Q1-952208
Published purpose
The firm is developing a first-in-class therapeutic agent to prevent dangerously low blood sugar in insulin dependent Type 1 Diabetics. This project aims to demonstrate the same effect in Type 2 diabetics and prepare for a line extension to the Type 1 program already underway.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions